Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue.

Authors :: Viti V
Zanetta C
Capra R
Municchi A
Rocca MA
Filippi M
Source :: Journal of neurology [J Neurol] 2024 Sep; Vol. 271 (9), pp. 6368-6376. Date of Electronic Publication: 2024 Jul 11.
Publication Year :: 2024

Subjects :: Humans
Female
Multiple Sclerosis drug therapy
Adult
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting drug therapy
Antibodies, Monoclonal, Humanized adverse effects
Immunologic Factors adverse effects
Enteritis chemically induced

Full Text Access

Tools